Michael Rogers, Chief Financial Officer, and Rick Batycky, Chief Technology Officer, will present at the Deutsche Bank 41st Annual Health Care Conference in Boston on Wednesday, May 4 at 2:10 pm ET. A live audio webcast of the presentation can be accessed under “Investor Events” in the Investor section of the Acorda website or you may use the link:

http://edge.media-server.com/m/p/4a8mfxc4

Bank of America Merrill Lynch 2016 Health Care Conference

Michael Rogers, Chief Financial Officer and Andrew Blight, Chief Scientific Officer, will present at the Bank of America Merrill Lynch 2016 Health Care Conference in Las Vegas on Wednesday, May 11 at 8:00 am PT. A live audio webcast of the presentation can be accessed under “Investor Events” in the Investor section of the Acorda website or you may use the link:

https://www.veracast.com/webcasts/baml/healthcare2016/id11201470089.cfm

About Acorda Therapeutics

Founded in 1995, Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.

Acorda has an industry leading pipeline of novel neurological therapies addressing a range of disorders, including Parkinson’s disease, epilepsy, post-stroke walking deficits, migraine, and multiple sclerosis. Acorda markets three FDA-approved therapies, includingAMPYRA® (dalfampridine) Extended Release Tablets, 10 mg.

For more information, please visit the Company’s website at: www.acorda.com.

Contacts

Acorda Therapeutics
Felicia Vonella, 914-326-5146
[email protected]